Consistent with a role for NFE2L2 in vitamin D-mediated cancer prevention, a number of NFE2L2 target genes were increased in RWPE1 cells after 1,25(OH)2D treatment, e.g. GPX3, HMOX1, AKR1C2, and TXNRD1. The gene discussed is TXNRD1; the disease is cancer.